- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-33-0001359

Ardor Drugs Private Limited
About Ardor Drugs Private Limited
Data last updated:
Ardor Drugs Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 June 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1999PTC036199. Its GSTIN is 24AADCA0407F1ZG (Gujarat).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors including Harshal Prafulla Desai and Munna Kumar Kushwaha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1/1225B Office – 403 4th Floor Liberty Chamber Timaliyawad Nanpura, Surat, Gujarat, India – 395001.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.04 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹12.79 Lakh (net margin 1.1%) and EBITDA of ₹57.01 Lakh (EBITDA margin 4.7%). Revenue has declined at a compounded annual rate (CAGR) of 2% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5.66 Cr and satisfied charges of ₹80 Lakh on record. Court records list 12 cases involving the company, including 12 filed against it; 4 cases are pending.
Ardor Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-33-0001359). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Ardor Drugs
Contact details
Ardor Drugs Private Limited's registered office is in Surat, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1/1225B Office – 403 4th Floor Liberty Chamber Timaliyawad Nanpura, Surat, Gujarat, India – 395001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ardor Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ardor Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ardor Drugs Private Limited, buy the company report.
Financials of Ardor Drugs Private Limited
FY 2024 filings availableArdor Drugs Private Limited reported revenue of ₹12.04 Cr (down 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 33% fall in the latest year. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹57.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.79 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ardor Drugs Private Limited, buy the company report.
Board of directors of Ardor Drugs Private Limited
Ardor Drugs has 4 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshal Prafulla Desai Also directs: Orlando Pharmaceutical Private Limited | Director | 13 Nov 2019 | 7 Years 0 Months | Current |
| Munna Kumar Kushwaha | Director | 23 Aug 2021 | 5 Years 2 Months | Current |
| Preyashi Harshal Desai | Director | 10 Oct 2025 | 1 Years 1 Months | Current |
| Dhruvraj Sanjaysinh Thakor | Director | 10 Oct 2025 | 1 Years 1 Months | Current |
Peer comparison
Ardor Drugs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abhimantrit Guruprasadam Ayurveda Herbal Foods Private Limited | ₹12.06 Cr (FY 2025) | 17.0% | New Delhi, Delhi, India | |||
| Hilsun Foods and Drugs Private Limited | ₹12.06 Cr (FY 2024) | 29.0% | Thane, Maharashtra, India | |||
| Ainesh Pharma Private Limited | ₹12.05 Cr (FY 2025) | -10.0% | Vijayawada, Andhra Pradesh, India | |||
| Ardor Drugs Private Limitedthis company | ₹12.04 Cr (FY 2025) | ₹12.79 Lakh | 1.1% | -33.0% | 1 | Surat, Gujarat, India |
| Dallas Drugs Private Limited | ₹12.01 Cr (FY 2025) | 138.0% | Chandigarh, India | |||
| T'walker's Pharmaceuticals Private Limited | ₹12 Cr (FY 2024) | 21.0% | Pune, Maharashtra, India |
To see the full peer comparison of Ardor Drugs Private Limited, buy the company report.
Auditor
Ardor Drugs Private Limited is audited by T DHOLAKIYA & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T DHOLAKIYA & CO | FY 2024 | 0151524W |
Shareholding
The shareholding of Ardor Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ardor Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Sep 2022 | 100628874 | Others | ₹1 Cr | Open | |
| 08 Sep 2022 | 100627647 | Others | ₹1 Cr | Open | |
| 07 Sep 2022 | 100648323 | Others | ₹1 Cr | Open | |
| 07 Sep 2022 | 100627642 | Others | ₹50 Lakh | Open | |
| 23 Jun 2010 | 10233457 | Punjab National Bank | ₹38.41 Lakh | Open |
To see the full charge records of Ardor Drugs Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Ardor Drugs Private Limited has 12 court cases on record: 12 filed against it. 4 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 9 | 1 |
| High courts | 3 | 3 | 3 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Interim or miscellaneous application | Filed against the company by Shalina Laboratories Pvt Ltd and 1 other | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Shalina Laboratories Private Ltd | Pending |
| High Court | Court case (COMIP) | Filed against the company by Shalina Laboratories Private Ltd and 1 other | Pending |
| District court, SURAT, Gujarat | Court case (NDPS) | Filed against the company by Government of India | Pending |
| District court, SURAT, Gujarat | Criminal complaint | Filed against the company by Shri D. N. Shah, Government Labour Officer and Bonus Payment Inspector, Tapi. | Disposed |
To see the full case history of Ardor Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ardor Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ardor Drugs Private Limited has a workforce of 1 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 1 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Ardor Drugs Private Limited, buy the company report.
GST
Ardor Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCA0407F1ZG | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ardor Drugs Private Limited, buy the company report.
Recent activity
Ardor Drugs Private Limited has 17 board changes on record since 2009: 4 appointments and 13 cessations. The latest: Dhruvraj Sanjaysinh Thakor was appointed as Director on 10 Oct 2025.
18 earlier events are in the company report.
Frequently asked questions
Ardor Drugs is an active private limited company based in Surat, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 June 1999 (27+ years old) and is registered under CIN U24231GJ1999PTC036199.
Ardor Drugs has 4 current directors:
- Harshal Prafulla Desai - Director
- Munna Kumar Kushwaha - Director
- Preyashi Harshal Desai - Director
- Dhruvraj Sanjaysinh Thakor - Director
The latest financial statements of Ardor Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Ardor Drugs is 24AADCA0407F1ZG, registered in Gujarat.
The CIN (Corporate Identification Number) of Ardor Drugs is U24231GJ1999PTC036199. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ardor Drugs has 12 court cases on record: 12 filed against it. 4 are pending. Most are in the district courts.
Ardor Drugs was incorporated on 20 June 1999, making it 27+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Ardor Drugs by revenue are Abhimantrit Guruprasadam Ayurveda Herbal Foods Private Limited, Hilsun Foods and Drugs Private Limited, Ainesh Pharma Private Limited, Dallas Drugs Private Limited, T'walker's Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dhruvraj Sanjaysinh Thakor was appointed as Director on 10 Oct 2025. Preyashi Harshal Desai was appointed as Director on 10 Oct 2025. Dhruvraj Sanjaysinh Thakor ceased to be Director on 04 Aug 2025. Ardor Drugs has 17 board changes on record in total.
Yes, Ardor Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-33-0001359).
The registered office of Ardor Drugs is at 11225B Office – 403 4th Floor Liberty Chamber Timaliyawad Nanpura, Surat, Gujarat, India – 395001.

